Effect of Bax deficiency on death receptor 5 and mitochondrial pathways during endoplasmic reticulum calcium pool depletion-induced apoptosis

Oncogene

Volumn 22, Issue 17, 2003, Pages 2674-2679

  He, Qin ^a   Montalbano, JoAnne ^a   Corcoran, Chad ^a   Jin, Weixin ^a   Huang, Ying ^a   Sheikh, M Saeed ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Apo2L TRAIL; Bax; Caspases; Cytochrome c; Death receptor 5; Thapsigargin

Indexed keywords

APO 2L ANTIGEN; CALCIUM ION; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; FAS ANTIGEN; PROTEIN BAX; PROTEIN BID; PROTEIN DEATH RECEPTOR 5; RECEPTOR PROTEIN; THAPSIGARGIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CALCIUM HOMEOSTASIS; CANCER CELL CULTURE; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DRUG MECHANISM; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; CALCIUM; CARCINOGENS; COLONIC NEOPLASMS; ENDOPLASMIC RETICULUM; HUMANS; MEMBRANE GLYCOPROTEINS; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; THAPSIGARGIN; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037516866     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206363     Document Type: Article

References (32)

1. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koepen H, Shahrokh Z and Schwall RH. (1999). J. Clin. Invest., 104, 155-162.
2. Boya P, Cohen I, Zamzami N, Vieira HLA and Kroemer G. (2002). Cell Death Differ., 9, 465-467.
3. Burns TF and El-Deiry WS. (2001). J. Biol. Chem., 276, 37879-37886.
4. Deng Y Lin Y and Wu X. (2002). Genes Dev., 16, 33-45.
5. Foyouzi-Youssefi R, Arnaudeau S, Broner C, Kelley WL, Tschopp J, Lew DP, Demaurex N and Krause KH. (2000). Proc. Natl. Acad. Sci. USA, 97, 5723-5728.
6. Furuya Y, Lundmo P, Short AD, Gill DL and Isaacs JT. (1994). Cancer Res., 54, 6167-6175.
7. He Q, Lee DI, Rong R, Yu M, Luo X, Klein M, El-Deiry WS, Huang Y, Hussain A and Sheikh MS. (2002a). Oncogene, 21, 2623-2633.
8. He Q, Luo X, Huang Y and Sheikh MS. (2002b). Oncogene, 21, 6032-6040.
9. Hsu YT, Wolter KG and Youle RJ. (1997). Proc. Natl. Acad. Sci. USA, 94, 3668-3672.
10. Huang Y, He Q, Rong R, Hillman MJ and Sheikh MS. (2001). Cancer Res., 61, 6918-6924.
11. Jin Z, Dicker DT and El-Deiry WS. (2002). Cell Cycle, 1, 82-89.
12. Johnstone RW, Ruefli AA and Lowe SW. (2002) Cell, 108, 153-164.
13. Kim BC, Kim HT, Mamura M, Ambudkar IS, Choi KS and Kim SJ. (2002). J. Biol. Chem., 277, 31381-31389.
14. Krebs J. (1998). BioMetals, 11, 375-382.
15. LeBlanc H, Lawrence D, Varfolomeev E, Totpal K, Morlan J, schow P, Fong S, Schwall R, Sinicropi D and Askenazi A. (2002). Nat. Med., 8, 274-281.
16. Mikhailov V, Mikhailova M, Degenhardt K, Venkatachalam MA, White E and Saikumar P. (2003). J. Biol. Chem., 278, 5367-5376.
17. Murphy AN, Bredesen E, Cortopassi G, Wang E and Fiskum G. (1996). Proc. Natl. Acad. Sci. USA, 93, 9893-9898.
18. Nechushtan A, Smith CL, Hsu YT and Youle RJ. (1999). EMBO J., 18, 2330-2341.
19. Nicholson DW. (2000). Nature, 407, 810-816.
20. Nutt LK, Chandra J, Pataer A, Fang B, Roth JA, Swisher SG, O'Neil RG and McConkey DJ. (2002a). J. Biol. Chem., 277, 20301-20308.
21. Nutt LK, Pataer A, Pahler J, Fang B, Roth JA, McConkey DJ and Swisher SG. (2002b). J. Biol. Chem., 277, 9219-9225.
22. Reed JC. (2002). Nat. Rev. Drug Dev., 1, 111-121.
23. Sagara Y and Inesi G, (1991). J. Biol. Chem., 266, 13503-13506.
24. Shimizu S, Eguchi Y, Kamiike W, Funahashi Y, Mignon A, Lacronique V, Matsuda H and Tsujimoto Y. (1998). Proc. Natl. Acad. Sci. USA, 95, 1455-1459.
25. Shimizu S, Narita M and Tsujimoto Y. (1999). Nature, 399, 483-487.
26. Tombal B, Denmeade SR, Gillis JM and Isaacs JT. (2002). Cell Death Differ., 9, 561-573.
27. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC and Lynch DH. (1999). Nat. Med., 5, 157-163
28. Wang X. (2001). Gene Dev., 15, 2922-2933.
29. Wertz IE and Dixit VM. (2000). J. Biol. Chem., 275, 11470-11477.
30. Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG and Youle RJ. (1997). J. Cell Biol., 139, 1281-1292.
31. Yang E and Korsmeyer SJ. (1996). Blood, 88, 368-401.
32. Zhang L, Yu J, Park BH, Kinzler KW and Vogelstein B. (2000). Science, 290, 989-992.